Brief: Tetra Bio-Pharma Opens New Subsidiary In Australia
06/06/2022 12:55
June 6 (Reuters) - Tetra Bio Pharma Inc TBP.TO :
* TETRA BIO-PHARMA OPENS NEW SUBSIDIARY IN AUSTRALIA AND
PROVIDES
REGULATORY UPDATE
* TETRA BIO PHARMA INC - COMPLETED ANNUAL LICENCE REVIEW
PROCESS
FOR OUR HEALTH CANADA DRUG ESTABLISHMENT LICENCE (DEL)
Source text for Eikon: ID:nCNWFxQw7a
Further company coverage: TBP.TO
((reuters.briefs@thomsonreuters.com;))
Recent news on Tetra Bio Pharma
See all newsBrief: Tetra Bio Receives A Second Clarifax From Health Canada Regarding Reduvo Risk Management Plan
Brief: Tetra Bio-Pharma Announces Results Of Artificial Intelligence Study Of ARDS-003 Combined With Favipiravir
Brief: Tetra Bio-Pharma Provides Update On Patent Applications For Novel Therapeutic Ards-003
Brief: Tetra Bio-Pharma Provides Update On Patent Applications For Novel Therapeutic Ards-003
Brief: Tetra And Prepaire Jointly Apply To Barda For Funding